Foundation for Prader-Willi Blog | Research (52)

Here is a recent study (link to abstract below) looking at the use of modafinil, a wake-promoting drug, in children with excessive daytime sleepiness (in this study, primarily narcolepsy).

New research has identified genes affected in Prader-Willi patients by deletion. Deletions account for approximately 70% of PWS cases. There are two different sizes of deletion, with one type encompassing more genes than the other.